Metraipolis › archive › dc_6fd3f64aef05

Severe immune-related autoimmune hemolytic anemia induced by pembrolizumab: a case report with novel immunosuppressive strategy — Europe PMC PMID:42183244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42183244
DOI
10.3389/fimmu.2026.1811425
License (as archived)
solo-consultazione
Archived
2026-11-02T15:45:48.455Z
SHA-256 of the archived text
e1c7a5edd1b7352c833b8f840d04d6074ff37a65dec6d10abcfd929f77d6770e
Stable URL of this page
https://metraipolis.com/documento/dc_6fd3f64aef05

How to cite

Severe immune-related autoimmune hemolytic anemia induced by pembrolizumab: a case report with novel immunosuppressive strategy — Europe PMC PMID:42183244 — Europe PMC (en), https://europepmc.org/article/MED/42183244 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fd3f64aef05 (Metraipolis archive dc_6fd3f64aef05, sha256 e1c7a5edd1b7352c833b8f840d04d6074ff37a65dec6d10abcfd929f77d6770e)
BibTeX
@misc{dc6fd3f64aef05,
  title = {Severe immune-related autoimmune hemolytic anemia induced by pembrolizumab: a case report with novel immunosuppressive strategy — Europe PMC PMID:42183244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42183244},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fd3f64aef05; sha256 e1c7a5edd1b7352c833b8f840d04d6074ff37a65dec6d10abcfd929f77d6770e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42183244. Agents can read the archived copy with the MCP tool read_document.